Nanoparticles in the ocular drug delivery
·Ocular drug transport barriers pose a challenge for drug delivery comprising the ocular surface epithelium, the tear film and internal barriers of the blood -aqueous and blood-retina barriers. Ocular drug delivery efficiency depends on the barriers and the clearance from the choroidal, conjunctival...
Saved in:
Published in | 国际眼科杂志:英文版 no. 3; pp. 390 - 396 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ·Ocular drug transport barriers pose a challenge for drug delivery comprising the ocular surface epithelium, the tear film and internal barriers of the blood -aqueous and blood-retina barriers. Ocular drug delivery efficiency depends on the barriers and the clearance from the choroidal, conjunctival vessels and lymphatic. Traditional drug administration reduces the clinical efficacy especially for poor water soluble molecules and for the posterior segment of the eye. Nanoparticles (NPs) have been designed to overcome the barriers, increase the drug penetration at the target site and prolong the drug levels by few internals of drug administrations in lower doses without any toxicity compared to the conventional eye drops. With the aid of high specificity and multifunctionality, DNA NPs can be resulted in higher transfection efficiency for gene therapy. NPs could target at cornea, retina and choroid by surficial applications and intravitreal injection. This review is concerned with recent findings and applications of NPs drug delivery systems for the treatment of different eye diseases. · |
---|---|
Bibliography: | Hong-Yan Zhou1,Ji-Long Hao1,Shuang Wang1,Yu Zheng1,Wen-Song Zhang21 Department of Ophthalmology, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin Province, China 2 Department of Ophthalmology, the Second Hospital of Jilin University, Changchun 130033, Jilin Province, China |
ISSN: | 2222-3959 2227-4898 |